Aimed at improving its prognosis in the long-term care space, Woonsocket, Rhode Island-based CVS Health Corp. plans to purchase Cincinnati-based Omnicare Inc. for $12.7 billion, including debt. Announced Thursday, the deal for Omnicare is expected to close by the end of the year.
Back in 2006, CVS picked up pharmacy benefits manager Caremark Rx Inc. for $21 billion, nearly double the price it’s putting up for Omnicare. Davis Polk & Wardwell took the lead for CVS on that deal, as well as the company’s subsequent $2.7 billion buy of Long Drugs in 2008 and first-ever international acquisition in 2013.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
